Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Medical Oncology
•
Thrombosis
•
Hematology
•
Hemostasis/Thrombosis
•
Primary Care
When do you consider indefinite anticoagulation in someone with first episode of distal/calf vein DVT?
Does your approach in this population differ compared to proximal DVTs?
Related Questions
How do you manage anticoagulation/antiplatelet therapies with strong indications for uninterrupted therapy in setting of urgent procedures?
How would you manage symptomatic, bilateral subsegmental PE developed after long air travel?
How would you approach hormone replacement therapy for perimenopause in a patient with increased risk factors for VTE (hereditary thrombophilia without personal thrombosis, family history of thrombophilia or thrombosis, etc.)?
For patients with newly diagnosed VTE on IV heparin planned for transition to DOAC, would you start at the loading or maintenance DOAC dose?
How do you manage anticoagulation in a patient with DVT from likely malignant mechanical obstruction?
How would you manage distal DVT in first trimester of pregnancy?
How would you manage superficial vein thrombosis that persists on imaging after treatment with full dose anticoagulation?
What are your top takeaways from ISTH 2025?
Is there a role for DOAC use for patients with unprovoked PE, that have had recent sleeve gastrectomy with duodenal bypass?
How do you decide between anticoagulation and observation for an incidentally detected subsegmental pulmonary embolism in elderly patients with a history of gastrointestinal bleeding?